Advertisement
UK markets close in 9 minutes
  • FTSE 100

    8,139.73
    +60.87 (+0.75%)
     
  • FTSE 250

    19,828.44
    +226.46 (+1.16%)
     
  • AIM

    755.01
    +1.89 (+0.25%)
     
  • GBP/EUR

    1.1662
    +0.0005 (+0.04%)
     
  • GBP/USD

    1.2452
    -0.0059 (-0.47%)
     
  • Bitcoin GBP

    51,174.39
    +165.05 (+0.32%)
     
  • CMC Crypto 200

    1,329.89
    -66.65 (-4.77%)
     
  • S&P 500

    5,096.17
    +47.75 (+0.95%)
     
  • DOW

    38,156.89
    +71.09 (+0.19%)
     
  • CRUDE OIL

    83.60
    +0.03 (+0.04%)
     
  • GOLD FUTURES

    2,345.60
    +3.10 (+0.13%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,163.28
    +246.00 (+1.37%)
     
  • CAC 40

    8,096.29
    +79.64 (+0.99%)
     

Analysts Just Made A Substantial Upgrade To Their Alector, Inc. (NASDAQ:ALEC) Forecasts

Shareholders in Alector, Inc. (NASDAQ:ALEC) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts. Consensus estimates suggest investors could expect greatly increased statutory revenues and earnings per share, with the analysts modelling a real improvement in business performance.

After the upgrade, the seven analysts covering Alector are now predicting revenues of US$67m in 2021. If met, this would reflect a major 211% improvement in sales compared to the last 12 months. Losses are presumed to reduce, shrinking 18% from last year to US$2.21. However, before this estimates update, the consensus had been expecting revenues of US$45m and US$2.63 per share in losses. We can see there's definitely been a change in sentiment in this update, with the analysts administering a sizeable upgrade to this year's revenue estimates, while at the same time reducing their loss estimates.

See our latest analysis for Alector

earnings-and-revenue-growth
earnings-and-revenue-growth

There was no major change to the consensus price target of US$42.50, perhaps suggesting that the analysts remain concerned about ongoing losses despite the improved earnings and revenue outlook. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Alector at US$57.00 per share, while the most bearish prices it at US$30.00. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

ADVERTISEMENT

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. For example, we noticed that Alector's rate of growth is expected to accelerate meaningfully, with revenues forecast to exhibit 9x growth to the end of 2021 on an annualised basis. That is well above its historical decline of 4.4% a year over the past three years. Compare this against analyst estimates for the broader industry, which suggest that (in aggregate) industry revenues are expected to grow 9.1% annually. So it looks like Alector is expected to grow faster than its competitors, at least for a while.

The Bottom Line

The most important thing here is that analysts reduced their loss per share estimates for this year, reflecting increased optimism around Alector's prospects. They also upgraded their revenue estimates for this year, and sales are expected to grow faster than the wider market. The lack of change in the price target is puzzling, but with a serious upgrade to this year's earnings expectations, it might be time to take another look at Alector.

Even so, the longer term trajectory of the business is much more important for the value creation of shareholders. We have estimates - from multiple Alector analysts - going out to 2023, and you can see them free on our platform here.

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies that insiders are buying.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.